Home > Result Summaries: Compounds > GSK557296 Result Summaries: GSK557296 GSKStudy ID Phase Title Summary (Download) 109059 phase 2 A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men with Premature Ejaculation (0 citation(s))
